BioPharma Credit PLC (LON: BPCR)
London flag London · Delayed Price · Currency is GBP · Price in USD
0.852
+0.002 (0.24%)
Dec 23, 2024, 4:35 PM BST

BioPharma Credit Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Cash & Equivalents
37.14135.05120.5394.71193.27296.64
Upgrade
Cash & Short-Term Investments
37.14135.05120.5394.71193.27296.64
Upgrade
Cash Growth
-45.28%12.05%27.26%-51.00%-34.85%-18.41%
Upgrade
Accounts Receivable
36.8820.2319.739.59015.87
Upgrade
Other Receivables
0.130.090.110.420.210.34
Upgrade
Receivables
37.0120.3219.8410.010.2116.21
Upgrade
Total Current Assets
74.15155.37140.37104.72193.48312.84
Upgrade
Long-Term Investments
1,1571,2011,2241,2661,1951,116
Upgrade
Total Assets
1,2321,3571,3641,3711,3881,429
Upgrade
Accrued Expenses
3.4515.8724.356.349.3924.5
Upgrade
Other Current Liabilities
--1.95---
Upgrade
Total Current Liabilities
3.4515.8726.36.349.3924.5
Upgrade
Long-Term Unearned Revenue
0.09-0.260.56--
Upgrade
Other Long-Term Liabilities
-----0.73
Upgrade
Total Liabilities
3.5415.8726.566.99.3925.24
Upgrade
Common Stock
13.7413.7413.7413.7413.7413.74
Upgrade
Additional Paid-In Capital
607.13607.13607.13607.13607.13607.13
Upgrade
Retained Earnings
607.21720716.59742.85758.05782.87
Upgrade
Shareholders' Equity
1,2281,3411,3371,3641,3791,404
Upgrade
Total Liabilities & Equity
1,2321,3571,3641,3711,3881,429
Upgrade
Net Cash (Debt)
37.14135.05120.5394.71193.27296.64
Upgrade
Net Cash Growth
-45.28%12.05%27.26%-51.00%-34.85%-18.41%
Upgrade
Net Cash Per Share
0.030.100.090.070.140.22
Upgrade
Filing Date Shares Outstanding
1,1991,2541,3191,3741,3741,374
Upgrade
Total Common Shares Outstanding
1,2191,3031,3191,3741,3741,374
Upgrade
Working Capital
70.7139.5114.0698.38184.08288.34
Upgrade
Book Value Per Share
1.011.031.010.991.001.02
Upgrade
Tangible Book Value
1,2281,3411,3371,3641,3791,404
Upgrade
Tangible Book Value Per Share
1.011.031.010.991.001.02
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.